With the recent convocation of the 119 th Congress, a change in administration, and resignation of USPTO Director Vidal, pharmaceutical patent reform is likely on the minds of many in Washington.

Among other elements of the bill are that it authorises the Federal Trade Commission (FTC) to enforce the prohibition and imposes limits on patent litigation involving biological products.

The 4 reasons why you might be a 'mosquito magnet' ...

Bonus Apr 08, 1994 May 03, 1994 Mar 24, 1994 Bonus Ratio: 2 share(s) for every 1 shares held Bonus Dec 04, 1992 Dec 22, 1992 Sep 30, 1992 Bonus Ratio: 1 share(s) for every 1 shares held Dr. Reddy's ...